Your browser doesn't support javascript.
loading
Severe Obstructive Sleep Apnea Is Associated with Alterations in the Nasal Microbiome and an Increase in Inflammation.
Wu, Benjamin G; Sulaiman, Imran; Wang, Jing; Shen, Nan; Clemente, Jose C; Li, Yonghua; Laumbach, Robert J; Lu, Shou-En; Udasin, Iris; Le-Hoang, Oanh; Perez, Alan; Alimokhtari, Shahnaz; Black, Kathleen; Plietz, Michael; Twumasi, Akosua; Sanders, Haley; Malecha, Patrick; Kapoor, Bianca; Scaglione, Benjamin D; Wang, Anbang; Blazoski, Cameron; Weiden, Michael D; Rapoport, David M; Harrison, Denise; Chitkara, Nishay; Vicente, Eugenio; Marin, José M; Sunderram, Jag; Ayappa, Indu; Segal, Leopoldo N.
Afiliación
  • Wu BG; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Sulaiman I; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Wang J; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Shen N; 2 Beijing Division of Pulmonary and Critical Care Medicine, Beijing Chaoyang Hospital, The Capital University of Medicine, Beijing, China.
  • Clemente JC; 3 Department of Genetics and Genomic Sciences.
  • Li Y; 4 Precision Immunology Institute, and.
  • Laumbach RJ; 3 Department of Genetics and Genomic Sciences.
  • Lu SE; 4 Precision Immunology Institute, and.
  • Udasin I; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Le-Hoang O; 5 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Perez A; 6 Environment and Occupational Health Sciences Institute, Rutgers Biomedical Health Sciences, Piscataway, New Jersey.
  • Alimokhtari S; 7 Rutgers School of Public Health, Piscataway, New Jersey.
  • Black K; 7 Rutgers School of Public Health, Piscataway, New Jersey.
  • Plietz M; 5 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Twumasi A; 6 Environment and Occupational Health Sciences Institute, Rutgers Biomedical Health Sciences, Piscataway, New Jersey.
  • Sanders H; 6 Environment and Occupational Health Sciences Institute, Rutgers Biomedical Health Sciences, Piscataway, New Jersey.
  • Malecha P; 6 Environment and Occupational Health Sciences Institute, Rutgers Biomedical Health Sciences, Piscataway, New Jersey.
  • Kapoor B; 5 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Scaglione BD; 8 Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Wang A; 8 Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Blazoski C; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Weiden MD; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Rapoport DM; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Harrison D; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Chitkara N; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Vicente E; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Marin JM; 8 Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Sunderram J; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Ayappa I; 1 Division of Pulmonary, Critical Care, and Sleep Medicine, New York University School of Medicine, New York, New York.
  • Segal LN; 9 Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Zaragoza, Spain; and.
Am J Respir Crit Care Med ; 199(1): 99-109, 2019 01 01.
Article en En | MEDLINE | ID: mdl-29969291
ABSTRACT
RATIONALE Obstructive sleep apnea (OSA) is associated with recurrent obstruction, subepithelial edema, and airway inflammation. The resultant inflammation may influence or be influenced by the nasal microbiome.

OBJECTIVES:

To evaluate whether the composition of the nasal microbiota is associated with obstructive sleep apnea and inflammatory biomarkers.

METHODS:

Two large cohorts were used 1) a discovery cohort of 472 subjects from the WTCSNORE (Seated, Supine and Post-Decongestion Nasal Resistance in World Trade Center Rescue and Recovery Workers) cohort, and 2) a validation cohort of 93 subjects rom the Zaragoza Sleep cohort. Sleep apnea was diagnosed using home sleep tests. Nasal lavages were obtained from cohort subjects to

measure:

1) microbiome composition (based on 16S rRNA gene sequencing), and 2) biomarkers for inflammation (inflammatory cells, IL-8, and IL-6). Longitudinal 3-month samples were obtained in the validation cohort, including after continuous positive airway pressure treatment when indicated. MEASUREMENTS AND MAIN

RESULTS:

In both cohorts, we identified that 1) severity of OSA correlated with differences in microbiome diversity and composition; 2) the nasal microbiome of subjects with severe OSA were enriched with Streptococcus, Prevotella, and Veillonella; and 3) the nasal microbiome differences were associated with inflammatory biomarkers. Network analysis identified clusters of cooccurring microbes that defined communities. Several common oral commensals (e.g., Streptococcus, Rothia, Veillonella, and Fusobacterium) correlated with apnea-hypopnea index. Three months of treatment with continuous positive airway pressure did not change the composition of the nasal microbiota.

CONCLUSIONS:

We demonstrate that the presence of an altered microbiome in severe OSA is associated with inflammatory markers. Further experimental approaches to explore causal links are needed.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apnea Obstructiva del Sueño / Microbiota / Cavidad Nasal Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Apnea Obstructiva del Sueño / Microbiota / Cavidad Nasal Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2019 Tipo del documento: Article